TriSalus Cash Conversion Cycle from 2010 to 2026

TLSI Stock   4.61  0.03  0.65%   
TriSalus Life's Cash Conversion Cycle is increasing with very volatile movements from year to year. Cash Conversion Cycle is estimated to finish at 208.75 this year. For the period between 2010 and 2026, TriSalus Life, Cash Conversion Cycle quarterly trend regression had mean deviation of  76.68 and range of 737. View All Fundamentals
 
Cash Conversion Cycle  
First Reported
2010-12-31
Previous Quarter
198.81
Current Value
208.75
Quarterly Volatility
159.38982369
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check TriSalus Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TriSalus Life's main balance sheet or income statement drivers, such as Tax Provision of 7.4 K, Interest Income of 279.1 K or Interest Expense of 3.7 M, as well as many indicators such as Price To Sales Ratio of 4.93, Dividend Yield of 0.0 or Days Sales Outstanding of 47.59. TriSalus financial statements analysis is a perfect complement when working with TriSalus Life Valuation or Volatility modules.
  
Build AI portfolio with TriSalus Stock
Check out the analysis of TriSalus Life Correlation against competitors.
The Cash Conversion Cycle trend for TriSalus Life Sciences offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether TriSalus Life is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest TriSalus Life's Cash Conversion Cycle Growth Pattern

Below is the plot of the Cash Conversion Cycle of TriSalus Life Sciences over the last few years. It is TriSalus Life's Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TriSalus Life's overall financial position and show how it may be relating to other accounts over time.
Cash Conversion Cycle10 Years Trend
Very volatile
   Cash Conversion Cycle   
       Timeline  

TriSalus Cash Conversion Cycle Regression Statistics

Arithmetic Mean43.65
Geometric Mean80.36
Coefficient Of Variation365.14
Mean Deviation76.68
Median56.51
Standard Deviation159.39
Sample Variance25,405
Range737
R-Value0.03
Mean Square Error27,075
R-Squared0.0009
Significance0.91
Slope0.94
Total Sum of Squares406,482

TriSalus Cash Conversion Cycle History

2026 208.75
2025 198.81
2024 220.9
2023 -48.46
2022 -516.05

About TriSalus Life Financial Statements

Investors use fundamental indicators, such as TriSalus Life's Cash Conversion Cycle, to determine how well the company is positioned to perform in the future. Although TriSalus Life's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Cash Conversion Cycle 198.81  208.75 

Currently Active Assets on Macroaxis

When determining whether TriSalus Life Sciences is a strong investment it is important to analyze TriSalus Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact TriSalus Life's future performance. For an informed investment choice regarding TriSalus Stock, refer to the following important reports:
Check out the analysis of TriSalus Life Correlation against competitors.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is there potential for Health Care Equipment & Supplies market expansion? Will TriSalus introduce new products? Factors like these will boost the valuation of TriSalus Life. If investors know TriSalus will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about TriSalus Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.12)
Revenue Per Share
1.217
Quarterly Revenue Growth
0.574
Return On Assets
(0.61)
Return On Equity
(4.96)
Investors evaluate TriSalus Life Sciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating TriSalus Life's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause TriSalus Life's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between TriSalus Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if TriSalus Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, TriSalus Life's market price signifies the transaction level at which participants voluntarily complete trades.